Cargando…

Role of abatacept in the prevention of graft-versus-host disease: current perspectives

Administration of abatacept following transplantation has been reported to inhibit graft rejection and graft-versus-host-disease (GvHD) in mouse models associated with allogeneic hematopoietic stem cell transplant (HSCT). This strategy has recently been adopted in clinical practice for GvHD preventi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngwube, Alexander, Rangarajan, Hemalatha, Shah, Niketa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9943961/ https://www.ncbi.nlm.nih.gov/pubmed/36845849 http://dx.doi.org/10.1177/20406207231152644

Ejemplares similares

Abatacept as salvage therapy in chronic graft-versus-host disease—a retrospective analysis
por: Wertheimer, Tobias, et al.
Publicado: (2021)

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease
por: Abdelhakim, Haitham, et al.
Publicado: (2017)

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives
por: Toubai, Tomomi, et al.
Publicado: (2016)

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Novel regulatory therapies for prevention of Graft-versus-host disease
por: Leventhal, Joseph, et al.
Publicado: (2012)

Current treatment options for psoriatic arthritis: spotlight on abatacept
por: Ursini, Francesco, et al.
Publicado: (2018)

Resolution of Inflammation in Acute Graft-Versus-Host-Disease: Advances and Perspectives
por: Duarte, Layara Roberta Ferreira, et al.
Publicado: (2022)

Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives
por: Noisette, Ashley, et al.
Publicado: (2018)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease
por: Chen, Yuanyuan, et al.
Publicado: (2015)

Current Status and Future Directions in Graft-Versus-Host Disease Prevention Following Allogeneic Blood and Marrow Transplantation in Adults
por: Tegla, Cosmin, et al.
Publicado: (2020)

The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease
por: Rhoades, Ruben, et al.
Publicado: (2017)

The Role of MicroRNA in Graft-Versus-Host-Disease: A Review
por: Pitea, Martina, et al.
Publicado: (2023)

The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease
por: Zhao, Lu, et al.
Publicado: (2019)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Abatacept in the treatment of rheumatoid arthritis
por: Buch, Maya H, et al.
Publicado: (2008)

Abatacept in the treatment of rheumatoid arthritis
por: Vital, Edward M, et al.
Publicado: (2006)

Abatacept treatment for rheumatoid arthritis
por: Schiff, Michael
Publicado: (2011)

Current data on IL-17 and Th17 cells and implications for graft versus host disease
por: Normanton, Marília, et al.
Publicado: (2013)

Role of Toll-Like Receptor Signaling in the Pathogenesis of Graft-versus-Host Diseases
por: Tu, Sanfang, et al.
Publicado: (2016)

Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
por: Abboud, Ramzi, et al.
Publicado: (2020)

The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
por: Biliński, Jarosław, et al.
Publicado: (2022)

Update on ocular graft-versus-host disease
por: Nair, Sridevi, et al.
Publicado: (2021)

T cell metabolism in graft-versus-host disease
por: Zou, Yujing, et al.
Publicado: (2020)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Editorial: Controversies and expectations for prevention and treatment of graft-versus-host-disease: a biological and clinical perspective
por: Mariotti, Jacopo, et al.
Publicado: (2023)

Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease
por: Lin, Yi, et al.
Publicado: (2011)

Role of endothelial cells in graft-versus-host disease
por: Neidemire-Colley, Lotus, et al.
Publicado: (2022)

T-Cell Manipulation Strategies to Prevent Graft-Versus-Host Disease in Haploidentical Stem Cell Transplantation
por: Vadakekolathu, Jayakumar, et al.
Publicado: (2017)

Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013)

Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease
por: Braun, Lukas M., et al.
Publicado: (2021)

Effect of Vitamin D on Graft-versus-Host Disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2022)

Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023)

Subcutaneous Abatacept vErsus Intravenous Abatacept: A Phase IIIb Noninferiority Study in Patients With an Inadequate Response to Methotrexate
por: Genovese, M C, et al.
Publicado: (2011)

The Role of Myeloid-Derived Suppressor Cells (MDSCs) in Graft-versus-Host Disease (GVHD)
por: Demosthenous, Christos, et al.
Publicado: (2021)

Subcutaneous abatacept for the treatment of rheumatoid arthritis
por: Schiff, Michael
Publicado: (2013)

Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment
por: Strong Rodrigues, Karla, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4gi13m339bii9951njbn27epa7